Coversyl Plus Arginine

Quick links

Choose a section

Quick links to important sections

Advertisements

Coversyl Plus Arginine

Advertisements
Advertisements

Overview of Coversyl Plus Arginine

Property Description
Active ingredients Perindopril Arginine, Indapamide
Form Film-coated tablets
Pharmacological class Antihypertensive agents
Common use Management of high blood pressure
Origin Synthetic

What Type of Medicine is Coversyl Plus Arginine?

Coversyl Plus Arginine is a prescription-only, fixed combination antihypertensive agent that belongs to the broad class of medicines used for managing essential hypertension, or high blood pressure. This dual-component medication is entirely synthetic in origin and is administered orally as a film-coated tablet. It is clinically recognized for its role in supporting the circulatory system's function, particularly when a single agent is insufficient for control. As a fixed combination, this approach is often recommended for adult patients whose blood pressure requires management through multiple pharmacological pathways, representing a targeted strategy in cardiovascular management.


Active Composition: Perindopril Arginine and Indapamide

The composition includes the two active ingredients, Perindopril Arginine and Indapamide. Perindopril Arginine is classified as an Angiotensin-Converting Enzyme (ACE) Inhibitor, a class of drug that works by interfering with the body's natural system for regulating blood pressure. The second component, Indapamide, is a thiazide-like diuretic, which is chemically related to sulfonamide derivatives. The specific use of the L-arginine salt in this formulation is a distinguishing feature, designed to enhance the stability of the Perindopril component compared to older salt forms, while delivering the same active metabolite.


General Purpose: Dual Action for Managing High Blood Pressure

The primary purpose is to harness the synergistic action of its two agents to achieve antihypertensive efficacy. This dual therapeutic approach involves two complementary mechanisms: the ACE inhibitor component promotes vessel relaxation, while the diuretic component facilitates fluid reduction by assisting the kidneys in removing excess salt and water. This strategy is typically used when a patient's high blood pressure requires management through both the dilation of blood vessels and a reduction in blood volume.

Regulatory References

  1. Perindopril Monograph (NIH/NLM)
Advertisements

What side effects are possible with Coversyl Plus Arginine?

Possible Side Effects and Safety Information

The safety profile for Coversyl Plus Arginine, a fixed-combination antihypertensive, is defined by regulatory documents based on the known effects of its two active components, Perindopril (an ACE Inhibitor) and Indapamide (a thiazide-like diuretic). The potential adverse reactions are officially classified by frequency and System-Organ Class (SOC).

Common Adverse Reactions (affecting 1 to 10 users in 100) often involve the Nervous System (dizziness, headache, paresthesia) and the Respiratory System (cough). Other common effects include Gastrointestinal disturbances (nausea, vomiting, dyspepsia, constipation, diarrhea) and general symptoms like asthenia (weakness) and muscle cramps.

Serious Adverse Reactions are explicitly documented by regulatory authorities, although they may occur uncommonly or very rarely.

  • Angioedema: A severe, potentially life-threatening swelling of the face, lips, tongue, or throat, associated with the ACE inhibitor component.
  • Hepatic Encephalopathy: A serious risk associated with the Indapamide component, particularly when pre-existing severe hepatic impairment is present, leading to contraindication in this setting.

The official label states that a significant drop in blood pressure (hypotension) is more likely at the start of treatment or following a dose increase. Use is also restricted by explicit contraindications, including a history of angioedema linked to previous ACE inhibitor use and severe renal failure. Throughout the duration of use, regular monitoring of electrolyte levels (e.g., potassium and sodium) and renal function is required due to the combined effects of the medication on these metabolic parameters.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for an overdose of Coversyl Plus Arginine centers on severe hemodynamic instability and electrolyte and fluid depletion due to the combined effects of the active ingredients.


Documented Clinical Manifestations

The most frequent sign of overdosage is marked hypotension (severe low blood pressure). Other documented clinical presentations include systemic disturbances such as dizziness, sleepiness, nausea, vomiting, and muscle cramps. The overdose may affect the urinary system, leading to a reduction in output, progressing from oliguria to potential anuria (absence of urine) or acute renal failure.


Required Emergency Actions

An overdose is considered a serious event, and regulatory guidance mandates that patients seek immediate medical help or contact the nearest hospital casualty department immediately. If marked low blood pressure is observed, the patient should be placed in the supine position with legs elevated to counter the effects. There is no specific pharmacological antidote documented in the regulatory labeling. However, supportive measures, including the restoration of fluid and electrolyte balance and decontamination procedures like gastric lavage or activated charcoal, are officially described management steps. The active metabolite, Perindoprilat, is known to be dialyzable.

Advertisements

Therapeutic Uses of Coversyl Plus Arginine

What Coversyl Plus Arginine Treats: Main Uses and Benefits

This medication is commonly used to help with the long-term management of high blood pressure in adults. The primary therapeutic domain of this medication involves the management of high blood pressure when additional supportive management is needed.

The medication is applied across domains where additional symptomatic support is relevant, and it supports patients during episodes of heightened discomfort associated with chronic systemic imbalance. The therapeutic scope is relevant for conditions associated with chronic systemic imbalance and symptoms that interfere with daily functioning, such as fluid retention.

“The medication is applied across domains where additional symptomatic support is needed, and supports patients during episodes of heightened discomfort.”


Quick Facts: Therapeutic Support

  • Chronic Conditions: Relevant for conditions characterized by periods of heightened symptoms related to systemic imbalance.
  • Symptom Easing: Is applied in addressing symptoms that create noticeable physiological strain, such as fluid retention and swelling in the extremities.
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Coversyl Plus Arginine?

The eligibility profile for Coversyl Plus Arginine is strictly defined by regulatory authorities and centers on patient age, medical history, and concurrent health conditions. It is indicated exclusively for the treatment of essential hypertension in adult patients (18 years and older).


Official Restrictions and Contraindications

Category Status and Key Restriction
Age Group Adults Only. Not recommended for children and adolescents as safety and efficacy have not been established in this population.
Pregnancy Contraindicated in the second and third trimesters. Not recommended in the first trimester or while breastfeeding
Organ Function Contraindicated in severe hepatic impairment or hepatic encephalopathy, severe renal impairment (CrCl < 30 ml/min), and hypokalaemia (low blood potassium).
Allergic History Contraindicated in patients with a history of angioedema (associated with previous ACE inhibitor use, hereditary, or idiopathic causes).
Other Conditions Contraindicated in untreated decompensated heart failure and in patients receiving specific extracorporeal treatments (e.g., dialysis with negatively charged membranes).

These rules ensure the medicine is only used by populations where the risk profile is deemed acceptable by regulatory standards. Use requires extreme caution or is prohibited in specific cases of compromised kidney or liver function, and a known angioedema history.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes documented interaction patterns based on official government regulatory documentation.

Contraindicated Combinations and Mandatory Restrictions

The co-administration of Sacubitril/Valsartan is strictly prohibited due to the documented risk of angioedema; a mandatory 36-hour wash-out period must separate the last dose of Sacubitril/Valsartan and the first dose of this medication. The use of Aliskiren is officially contraindicated in patients with diabetes mellitus or renal impairment (GFR < 60 ml/min/1.73 m^2). Furthermore, specific extracorporeal treatments involving high-flux polyacrylonitrile membranes are prohibited due to the risk of severe anaphylactoid reactions.

Combinations Generally Not Recommended

Interactions with substances that increase serum potassium are generally not recommended due to the risk of hyperkalemia. This includes Potassium-sparing diuretics, Potassium supplements, and Potassium-containing salt substitutes. Co-administration with Lithium is also not recommended, as it is documented to increase serum lithium plasma concentration, raising the potential for toxicity.

Other Documented Pharmacodynamic Interactions

Combining the drug with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is documented to reduce the antihypertensive effect and increase the risk of renal function deterioration. Concomitant use with agents such as mTOR inhibitors, Racecadotril, or Gliptins may result in an increased risk of angioedema. Additionally, alcohol is officially documented to have an additive effect in lowering blood pressure. Co-administration with other Angiotensin II Receptor Blockers (ARBs) is not recommended due to the risks associated with dual RAAS blockade.

Advertisements

Mechanism of Action

Coversyl Plus Arginine is a combination pharmaceutical product comprising perindopril arginine and indapamide. Perindopril arginine is a prodrug that undergoes hydrolysis in vivo to form the active metabolite, perindoprilat. Perindoprilat functions as a competitive inhibitor of the Angiotensin-Converting Enzyme (ACE). By binding to the ACE active site, it blocks the catalytic conversion of angiotensin I to the potent vasoconstrictor angiotensin II.

The inhibition of ACE interrupts the Renin-Angiotensin-Aldosterone System (RAAS) cascade, resulting in reduced circulating levels of angiotensin II. A secondary consequence of ACE blockade is the decreased breakdown of the vasodilator bradykinin. Concurrently, the second component, indapamide, exerts its action primarily on the distal convoluted tubule of the nephron. Indapamide is an inhibitor that modulates fluid and electrolyte balance by blocking the reabsorption of sodium and chloride ions from the tubular lumen.

The combined activity of these two agents leads to two distinct system-level physiological consequences: vasodilation and extracellular volume reduction. Perindoprilat-mediated suppression of angiotensin II and preservation of bradykinin facilitates the relaxation of vascular smooth muscle. Indapamide's mechanism on the renal tubules promotes the excretion of water and electrolytes, contributing to a measurable decrease in circulating fluid volume.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

Coversyl Plus Arginine is intended for oral administration only, taken as a film-coated tablet. The official usage protocol mandates a strict once-daily dosing schedule to maintain consistent blood pressure management, which is a pattern established for long-term therapy.

Administration is specifically instructed to occur in the morning and before a meal (on an empty stomach). This instruction ensures proper absorption of the perindopril component. The tablet must be swallowed whole with water.

Dosing and Titration Principles

The medicine is available in several fixed-dose strengths, and the regimen is typically started at the lowest strength, such as 2.5 mg perindopril arginine / 0.625 mg indapamide. If blood pressure remains inadequately controlled after an appropriate period (e.g., approximately one month) at one strength, the dosage may be adjusted to the next higher available strength, up to the maximum fixed combination dose of 10 mg perindopril arginine / 2.5 mg indapamide. This process of adjustment is known as titration.

Dose Strength (Perindopril Arginine / Indapamide) Usage Principle (Standard Adult)
2.5 mg / 0.625 mg Standard starting point for fixed-combination use.
5 mg / 1.25 mg Used if control is insufficient on the lower dose.

Population-Specific Use

Specific limitations exist for certain patient groups. Treatment initiation in older adults requires consideration of their renal function and typically starts at the lowest strength. For individuals with moderate renal impairment (creatinine clearance between 30 and 60 mL/min), the dose is limited to a maximum of one 2.5 mg / 0.625 mg tablet per day. The fixed combination is not recommended for use in children and adolescents due to a lack of established data.

Handling Missed Doses

If the administration time is missed, the patient should simply take the next scheduled dose at the usual time; it is explicitly instructed not to take the missed dose or double the subsequent dose to compensate.

Advertisements

Recent Clinical Evidence

Research Evidence Overview

Evidence for Managing Essential High Blood Pressure

Research has examined this combination therapy in clinical settings involving high blood pressure, or essential hypertension, in adults. Randomized Controlled Trials (RCTs) primarily evaluated patients who were newly diagnosed or whose blood pressure was observed to be uncontrolled on previous single treatments. Studies examined changes in both systolic and diastolic blood pressure measurements from the start of the study, as well as the percentage of participants whose blood pressure was monitored against pre-defined target ranges. The findings describe patterns where studies reported measurements of blood pressure reduction across the populations studied.


Evidence in High-Risk Populations

Beyond blood pressure measurement, the combination was studied for its evaluation in research contexts involving high-risk patients. Large, long-term RCTs, notably including the ADVANCE and PROGRESS trials, monitored the incidence of serious events like stroke, non-fatal heart attack, and cardiovascular death over periods of up to four years in populations with existing risk factors, such as those with a history of stroke or Type 2 Diabetes Mellitus. The research describes the patterns observed in the high-risk populations regarding the occurrence of these major events.


Limitations and Evidence Gaps

Long-term effects are not fully established specifically for the lower-risk general hypertensive population, as most initial trials focused on shorter durations. Furthermore, comparative evidence is lacking that directly compares this specific combination against every other modern dual-combination regimen. Some subgroup findings are uncertain due to reliance on data from smaller or less controlled observational studies, and data for certain groups remain insufficient, such as pediatric populations.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Coversyl Plus Arginine (FAQ)


Q: Is Coversyl Plus Arginine the same as Coversyl Arginine, or is it different?

Coversyl Plus Arginine is a fixed combination medication. According to official product information, it contains two active ingredients: perindopril arginine and the diuretic indapamide. Coversyl Arginine, in contrast, is the single-agent product that contains only perindopril arginine.


Q: Why is the Perindopril in this drug formulated with Arginine?

The perindopril component is formulated as the L-arginine salt primarily to enhance its stability. Official documents describe this specific salt form as a distinguishing feature used to maintain the quality of the perindopril component.


Q: How does the Arginine component affect the Perindopril and Indapamide?

Official information indicates that the L-arginine salt is used to enhance the stability of the perindopril component itself. It is not described as directly changing the way the perindopril or indapamide work within the body to lower blood pressure.


Q: How quickly should I expect to see an effect after starting Coversyl Plus Arginine?

The active substance in perindopril reaches its peak concentration in the body in a few hours, and a stable level of the drug is typically reached within about four days. The maximum blood pressure-lowering effect is typically assessed after approximately one month of treatment.


Q: How long does the effect of one tablet of Coversyl Plus Arginine last?

The active compound is eliminated from the body slowly, with a half-life of about 17 hours. This prolonged duration supports the established protocol of a once-daily dosing schedule.


Q: Can Coversyl Plus Arginine cause a persistent dry cough?

A cough is listed in regulatory documents as a common adverse reaction for this type of medication. For ACE inhibitors like perindopril, this cough is typically described as being dry and persistent.


Q: Is it normal to feel dizzy or lightheaded when first starting this medicine?

Dizziness is a common adverse reaction listed in official product information. Symptomatic low blood pressure (hypotension), which can cause lightheadedness, is documented to be more likely when treatment is first initiated or following a dose increase.


Q: Is it safe to use Coversyl Plus Arginine if I have kidney issues?

This medication is contraindicated (should not be used) if you have severe kidney insufficiency. For individuals with moderate kidney issues, the maximum allowable dose is generally lower. The use of this drug in patients with any kidney issue requires careful monitoring.


Q: Can a patient with liver disease take Coversyl Plus Arginine?

Official regulatory documents state that this medication is contraindicated in cases of severe liver impairment or related conditions like hepatic encephalopathy. In patients with non-severe liver disease, cautious use and monitoring are generally advised.


Q: Can I take Coversyl Plus Arginine if I have diabetes?

Use in patients with diabetes requires close monitoring of blood sugar levels, particularly when treatment begins. Official documents note that the medication may affect blood sugar, and a specific co-treatment (Aliskiren) is contraindicated in diabetic patients also taking Coversyl Plus.


Q: Can Coversyl Plus Arginine affect my blood sugar levels?

Official product information indicates the medication can affect blood sugar levels. There is a documented potential for low blood sugar (hypoglycemia) in patients with diabetes who are taking oral antidiabetic medicines or insulin. Monitoring of blood sugar is advised for these patients.


Q: Is Coversyl Plus Arginine effective for people with both high blood pressure and heart failure?

This fixed combination product is licensed and indicated only for the treatment of essential hypertension (high blood pressure) in adults. It is contraindicated in patients who have untreated decompensated heart failure.


Q: Does this medicine interact with common pain relievers like ibuprofen?

Official regulatory documents caution that anti-inflammatory medicines like ibuprofen are documented to potentially reduce the blood pressure-lowering effect of this drug. This combination may also increase the risk of deterioration in kidney function.


Q: Can I use salt substitutes containing potassium while on this drug?

Official guidance states that potassium-containing salt substitutes are generally not recommended. This is because the perindopril component can increase blood potassium levels, and using these substitutes may increase the risk of developing dangerously high potassium (hyperkalemia).


Q: Does taking this medication mean I have to limit my potassium intake?

The combination of the active ingredients requires caution and regular monitoring of serum potassium levels. While official product information strongly advises against using potassium supplements or potassium-containing salt substitutes, official product information does not include specific instruction on limiting potassium intake from common foods.


Q: Are there any common foods or drinks that interfere with this drug?

The medication is specifically instructed to be taken in the morning before a meal (on an empty stomach) to ensure proper absorption. Aside from this timing, the only substance officially noted for interaction is potassium-containing salt substitutes.


Q: Is it safe to drink alcohol in moderation while on this medication?

Official documentation notes that alcohol has an additive effect in lowering blood pressure. This may increase the risk of side effects like dizziness or lightheadedness, particularly when treatment is started or the dose is changed.


Q: Is it required to have blood tests done while taking Coversyl Plus Arginine?

Official use includes the requirement for regular monitoring of certain parameters. This involves checking the function of the kidneys (creatinine) and the levels of electrolytes, such as potassium, in the blood.


Q: Is there a risk of skin sensitivity to sunlight with Coversyl Plus Arginine?

Official product information for the indapamide component lists photosensitivity reactions as a possible adverse effect. This means there is a chance of increased skin sensitivity to sunlight or UV light exposure.


Q: Are there any mood changes or depression linked to using this drug?

Official regulatory documents list certain uncommon adverse effects on the nervous system. These include possible mood disturbances or sleep disturbances.


Q: Are there warnings about driving or operating machinery while using this drug?

Yes, official warnings exist. Because the medication can cause side effects like dizziness or fatigue, especially at the start of treatment or when alcohol is consumed, patients are advised that their ability to drive or operate machinery may be impaired.


Q: Is it true that Coversyl Plus Arginine can cause a drop in blood pressure when standing up?

Orthostatic hypotension (a drop in blood pressure upon standing, often causing dizziness) is listed as a common adverse reaction in official product information. This effect is a known possibility with combination blood pressure medicines.


Q: Can Coversyl Plus Arginine interact with herbal remedies?

General patient guidance advises that you should inform your doctor or pharmacist about all medicines, vitamins, or natural products/supplements you are using. This is a common precaution for blood pressure medications to check for potential interactions.


Q: Can I take multivitamins or supplements with Coversyl Plus Arginine?

Official product information warns specifically against potassium supplements. General guidance for supplements suggests that specific interactions with the active ingredients should be verified with a healthcare provider.


Advertisements

How should Coversyl Plus Arginine be stored and disposed of?

Storage and Disposal of Coversyl Plus Arginine

The storage and disposal of this medicine are governed by specific regulatory requirements to maintain its stability and ensure environmental safety.


Official Storage Conditions

Coversyl Plus Arginine tablets must be stored at a temperature below 30 C in a dry environment. It is mandatory to keep the medication out of the sight and reach of children and to retain it in the original container with the lid tightly closed to protect it from moisture. Do not use the tablets after the expiry date printed on the carton and container.


Required Disposal Instructions

Do not dispose of this medicine via wastewater or general household waste. Disposal must follow pharmaceutical waste protocols. You must ask your pharmacist how to properly throw away unused or expired medicines; these measures are necessary to help protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Coversyl Plus Arginine found in:

A-Z Index: